Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Diabetic nephropathy (DN) is a major complication of diabetes mellitus.
• Podocyte injury is a key factor in DN pathogenesis.
• Cyclooxygenase-2 (COX-2) expression is elevated in DN and its inhibition shows therapeutic potential in animal models.

Purpose of the Study:

• To investigate the specific role of podocyte-derived COX-2 in the development of diabetic nephropathy.
• To elucidate the molecular mechanisms linking podocyte COX-2 to glomerular injury.

Main Methods:

• Utilized a streptozotocin-induced diabetes model in wild-type and podocyte-specific COX-2 transgenic mice.
• Assessed kidney function (albuminuria, GFR), blood pressure, and performed histological analysis.
• Investigated high glucose effects on cultured podocytes overexpressing COX-2, focusing on (pro)renin receptor expression and renin-angiotensin system activation.
• Examined the impact of COX-2 inhibition in vivo.

Main Results:

• Diabetic COX-2 transgenic mice developed progressive albuminuria and glomerular injury (foot-process effacement, mesangial expansion, GBM thickening) compared to wild-type mice.
• High glucose induced injury and increased (pro)renin receptor expression in cultured podocytes overexpressing COX-2.
• Downregulation of the (pro)renin receptor attenuated high glucose-induced podocyte injury.
• In vivo, COX-2 inhibition reduced podocyte (pro)renin receptor expression, albuminuria, and histological damage in diabetic transgenic mice.

Conclusions:

• Elevated podocyte COX-2 expression significantly contributes to the development of diabetic glomerular injury.
• The (pro)renin receptor is implicated as a mediator in COX-2-induced podocyte susceptibility to injury in diabetes.
• Targeting podocyte COX-2 and potentially the (pro)renin receptor pathway may represent a novel therapeutic approach for diabetic nephropathy.